Valsartan

Valsartan belongs to a new and rapidly growing group of drugs known as angiotensin receptor antagonists. itsimilar to losartan. Valsartan antagonizes angiotensin II at the AT1 receptor subtype. Two angiotensin II receptors, AT1 and AT 2, have been identified. Angiotensin II is the primary vasoactive hormone of the renin-angiontensin system and plays an important role in the pathophysiology of hypertension and congestive heart failure. Valsartan is currently approved as an oral antihypertensive agent, either alone or in combination with other antihypertensive agents. Valsartan reduces left ventricular hypertrophy, although the clinical benefValsartan associated with reducing LV hypertrophy is not well established. Unlike losartan, Valsartan has no effect on serum uric acid. Valsartan was FDA approved for the treatment of hypertension on 23rd december 1996.


Adult Dose
Dose: 80 to 160 mg
Single Dose: 120 (120)
Frequency: 24 hourly
Route: PO
Instructions:
Neonatal
Paedriatic
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Characteristics
. It is of Synthetic origin and belongs to Valine. It belongs to Antihypertensive Agents pharmacological group.The Molecular Weight of Valsartan is 435.50.
Contraindications
Valsartan
Effects
The severe or irreversible adverse effects of Valsartan, which give rise to further complications include Hyperkalemia, Anemia, Angioedema, Azotemia.The symptomatic adverse reactions produced by Valsartan are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Abdominal pain, Cough.
Indications
Valsartan is primarily indicated in conditions like Chronic congestive heart failure, Hypertension, Myocardial infarction.
Interactions
Valsartan is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementDoxorubicin (HCl)LacosamidePotassium GlycerophosphateConcurrent use may cause too much potassium in the blood. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interfrence
Risks
Drug should not be given to Paediatrics, Pregnant Mothers, Cardiac / Hypertensive Patients, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Caps Store Below 40°C. Protect from Sunlight and Heat.
Warnings
Valsartan should be used with caution in patients with any pre-existing kidney or liver disease, congestive heart failure, diabetes or any allergy, especially drug allergy. To avoid dizziness and lightheadedness when rising from a seated or lying position, get up slowly. It should be used caution while performing tasks requiring alertness, because this medication causes dizziness. Caution is advised when this drug is used in the elderly persons. It is not recommended for use during pregnancy or lactation.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.